ArticleNature clinical practice. Nephrology2008

Dual inhibition with losartan and aliskiren: a promising therapeutic option for type 2 diabetic nephropathy?

Guntram SchernthanerPubMed ↗Publisher ↗

No numbers read from the abstract.